Michelle R. Rowland

Oncology
4321 Washington St Ste 4000
Kansas City, MO 64111

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

Journal: Gynecologic oncology
Published: July 11, 2025

Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.

Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.

Journal: JCO oncology practice
Published: May 22, 2024

Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer.

Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer.

Journal: PeerJ
Published: September 18, 2020

Factors influencing clinical trial enrollment among ovarian cancer patients.

Factors influencing clinical trial enrollment among ovarian cancer patients.

Journal: Gynecologic oncology
Published: May 30, 2017

Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women.

Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women.

Journal: Gynecologic oncology
Published: March 23, 2017

Contribution of age to clinical trial enrollment and tolerance with ovarian cancer.

Contribution of age to clinical trial enrollment and tolerance with ovarian cancer.

Journal: Gynecologic oncology
Published: October 19, 2016

Initiation of a formalized precision medicine program in gynecologic oncology.

Initiation of a formalized precision medicine program in gynecologic oncology.

Journal: Gynecologic oncology
Published: September 14, 2015

Treatment Advances in Locoregionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree That More Is Not Always Better?

Treatment Advances in Locoregionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree That More Is Not Always Better?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 20, 2015

Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older.

Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older.

Journal: American journal of obstetrics and gynecology
Published: September 24, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026